newsfilter
← Latest News
Business Wire·

Abcuro Appoints Darlene Deptula-Hicks to its Board of Directors

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells, today announced the appointment of Darlene Deptula-Hicks as a member of the company's Bo